Anaptysbio (ANAB) Announces FDA Approves JEMPERLI for dMMR Endometrial Cancer
Go back to Anaptysbio (ANAB) Announces FDA Approves JEMPERLI for dMMR Endometrial Cancer| (NASDAQ: ANAB) | Delayed: 19.26 -0.01 (0.05%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $19.27 | 52 Week High | $ | |||
| Open | $18.87 | 52 Week Low | $ | |||
| Day High | $19.26 | P/E | N/A | |||
| Day Low | $18.49 | EPS | $ | |||
| Volume | 39,532 | |||||
| GLAXOSMITHKLINE PLC (NYSE: GSK) | Delayed: 40.88 +0.02 (0.05%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $40.86 | 52 Week High | $45.58 | |||
| Open | $41.06 | 52 Week Low | $37.82 | |||
| Day High | $41.11 | P/E | N/A | |||
| Day Low | $40.86 | EPS | $0.00 | |||
| Volume | 718,712 | |||||
